Description
BLOOD AND BLOOD PRODUCTSXERCISE OPTION YEAR OF CONTRACT
Base award description: BLOOD AND BLOOD PRODUCTS FOR CTVHS, PO C00058
Modification chain · 16 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-10-01+$831,000= $831,000
- Mod 12010-09-21-$100,000= $731,000
- Mod 22010-10-01+$874,115= $1,605,115
- Mod 32010-10-28+$0= $1,605,115
- Mod 42010-11-10-$46,920= $1,558,195
- Mod 52011-10-01+$917,380= $2,475,575
- Mod P000062012-10-01+$820,928= $3,296,503
- Mod P000072013-03-27-$275,039= $3,021,464
- Mod P000082013-10-01+$489,586= $3,511,050
- Mod P000092014-09-29+$0= $3,511,050
- Mod P000102014-10-09+$84,040= $3,595,090
- Mod P000112014-12-16+$84,040= $3,679,130
- Mod P000122015-02-03-$30,554= $3,648,576
- Mod P000132015-03-18+$36,029= $3,684,605
- Mod P000142015-05-26-$65,127= $3,619,478
- Mod P000152019-01-02-$292,927= $3,326,552
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-10-01 | +$831,000 | $831,000 | BLOOD AND BLOOD PRODUCTS FOR CTVHS, PO C00058 |
| Mod 1· OTHER ADMINISTRATIVE ACTION | 2010-09-21 | −$100,000 | $731,000 | DEOBLIGATION OF PO C00016 BLOOD AND BLOOD PRODUCTS FOR CTVH |
| Mod 2· EXERCISE AN OPTION | 2010-10-01 | +$874,115 | $1,605,115 | EXERCISE OPTION YR. 1 |
| Mod 3· OTHER ADMINISTRATIVE ACTION | 2010-10-28 | +$0 | $1,605,115 | INCORPORATE VAAR CLAUSE 852.273-75 |
| Mod 4· OTHER ADMINISTRATIVE ACTION | 2010-11-10 | −$46,920 | $1,558,195 | DEOBLIGATION OF PO C00016 BLOOD AND BLOOD PRODUCTS FOR CTVHCS IN THE AMOUNT OF $46,920.00 |
| Mod 5· EXERCISE AN OPTION | 2011-10-01 | +$917,380 | $2,475,575 | C20015 TO EXERCISE OPTION YEAR OF CONTRACT |
| Mod P00006· EXERCISE AN OPTION | 2012-10-01 | +$820,928 | $3,296,503 | C30038 TO EXERCISE OPTION YEAR OF CONTRACT |
| Mod P00007· EXERCISE AN OPTION | 2013-03-27 | −$275,039 | $3,021,464 | C30038 TO EXERCISE OPTION YEAR OF CONTRACT |
| Mod P00008· EXERCISE AN OPTION | 2013-10-01 | +$489,586 | $3,511,050 | C30038 TO EXERCISE OPTION YEAR OF CONTRACT |
| Mod P00009· EXERCISE AN OPTION | 2014-09-29 | +$0 | $3,511,050 | C30038 TO EXERCISE OPTION YEAR OF CONTRACT |
| Mod P00010· FUNDING ONLY ACTION | 2014-10-09 | +$84,040 | $3,595,090 | C30038 TO EXERCISE OPTION YEAR OF CONTRACT |
| Mod P00011· FUNDING ONLY ACTION | 2014-12-16 | +$84,040 | $3,679,130 | BLOOD AND BLOOD PRODUCTSXERCISE OPTION YEAR OF CONTRACT |
| Mod P00012· CLOSE OUT | 2015-02-03 | −$30,554 | $3,648,576 | BLOOD AND BLOOD PRODUCTSXERCISE OPTION YEAR OF CONTRACT |
| Mod P00013· CLOSE OUT | 2015-03-18 | +$36,029 | $3,684,605 | BLOOD AND BLOOD PRODUCTSXERCISE OPTION YEAR OF CONTRACT |
| Mod P00014· CLOSE OUT | 2015-05-26 | −$65,127 | $3,619,478 | BLOOD AND BLOOD PRODUCTSXERCISE OPTION YEAR OF CONTRACT |
| Mod P00015· CHANGE ORDER | 2019-01-02 | −$292,927 | $3,326,552 | BLOOD AND BLOOD PRODUCTSXERCISE OPTION YEAR OF CONTRACT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RFL7D3RDNTN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0225 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $483,336 | FY2026 |
| 36C25726N0141 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,879,193 | FY2026 |
| 36C25725N0173 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $475,040 | FY2025 |
| 36C25725N0172 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $996,312 | FY2025 |
| 36C25724N0180 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $919,065 | FY2024 |
| 36C25724N0098 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $163,033 | FY2024 |
Other recipients under Q999 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726K0182 | PRIDE MOBILITY PRODUCTS CORPORATION | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $17,851 | FY2026 |
| 36C25726N0096 | GHOST RX INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $244,008 | FY2026 |
| 36C25725N0177 | GHOST RX INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $162,739 | FY2025 |
| 36C25724F0142 | COMPUTRITION, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $163,072 | FY2024 |
| 36C25724P0290 | FOXFIRE SCIENTIFIC, INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,830 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA257P0371_3600_-NONE-_-NONE- · retrieved 2026-09-26.